3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow ILiAD Biotechnologies: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pertussis Challenge Study in Adults Vaccinated With BPZE1 BPZE1, Placebo, Azithromycin - Pertussis/Whooping Cough, Bordetella Pertussis, Whooping Cough | Phase 2 | Completed | ILiAD Biotechnologies | 53 | 2022-06-20 | 2025-03-12 |
| Immunogenicity and Safety of BPZE1 Intranasal Pertussis Vaccine in Healthy School-age Children BPZE1 pertussis vaccine and placebo, BPZE1 pertussis vaccine and Boostrix, Placebo and Boostrix - Bordetella Pertussis, Whooping Cough | Phase 2 | Completed | ILiAD Biotechnologies | 368 | 2021-11-11 | 2025-11-06 |
| Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy Adults BPZE1 pertussis vaccine and VaxINator(TM) Atomization Device - Pertussis, Whooping Cough | Phase 2 | Completed | ILiAD Biotechnologies | 300 | 2019-06-15 | 2023-06-27 |
Whooping Cough (3) · Bordetella Infections (1) · Gram-Negative Bacterial Infections (1) · Infections (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1)
Azithromycin (1) · Boostrix (1)
United Kingdom (2) · Australia (1) · Costa Rica (1) · United States (1)
Barbara Rizzardi, MD (1) · Mary B Manning, MD (1) · Vicki Miller, MD (1)